Summit Securities Group’s Oscar Health OSCR Stock Holding History

Summit Securities Group’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,684	Closed	-$36.3K	–	1316
2026 Q1	$19.3K	Buy	+1,684	New	+$23.7K	﹤0.01%	530

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Summit Securities Group's OSCR Position: Q2 2026 in Review

Summit Securities Group sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 1,684 shares — an estimated $36.3K sold.

Summit Securities Group first reported a position in OSCR in Q1 2026 and held it in 1 quarter. The position peaked at $19.3K in Q1 2026. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Summit Securities Group reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 1,684 Oscar Health shares in Q2 2026, an estimated $36.3K.
Summit Securities Group first reported a position in Oscar Health in Q1 2026 and held it in 1 quarter.
Summit Securities Group's Oscar Health position peaked at $19.3K in Q1 2026.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.